Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 18 10:54AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.86 Insider Own- Shs Outstand4.53M Perf Week-2.30%
Market Cap13.46M Forward P/E- EPS next Y-1.11 Insider Trans- Shs Float4.08M Perf Month13.30%
Income-7.63M PEG- EPS next Q- Inst Own9.57% Short Float0.81% Perf Quarter23.70%
Sales0.74M P/S18.18 EPS this Y51.05% Inst Trans- Short Ratio0.69 Perf Half Y33.17%
Book/sh1.38 P/B1.96 EPS next Y24.49% ROA-79.22% Short Interest0.03M Perf Year-16.25%
Cash/sh1.79 P/C1.51 EPS next 5Y- ROE-142.49% 52W Range1.81 - 4.48 Perf YTD22.57%
Dividend Est.- P/FCF- EPS past 5Y48.75% ROI-122.03% 52W High-39.81% Beta1.49
Dividend TTM- Quick Ratio4.90 Sales past 5Y-22.15% Gross Margin- 52W Low48.98% ATR (14)0.34
Dividend Ex-Date- Current Ratio4.90 EPS Y/Y TTM50.36% Oper. Margin-1102.96% RSI (14)51.48 Volatility21.47% 11.51%
Employees5 Debt/Eq0.01 Sales Y/Y TTM-8.27% Profit Margin-1027.46% Recom1.00 Target Price15.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q67.30% Payout- Rel Volume10.02 Prev Close3.21
Sales Surprise0.00% EPS Surprise0.00% Sales Q/Q-21.32% EarningsMay 30 Avg Volume48.03K Price2.70
SMA201.86% SMA5016.43% SMA20020.62% Trades Volume122,543 Change-15.99%
Date Action Analyst Rating Change Price Target Change
Aug-11-17Initiated Maxim Group Buy $7
Oct-19-16Resumed ROTH Capital Buy
Aug-29-16Resumed Rodman & Renshaw Buy $6
Nov-30-15Reiterated H.C. Wainwright Buy $4 → $6
Mar-31-15Reiterated H.C. Wainwright Buy $7 → $3
Mar-30-15Downgrade ROTH Capital Buy → Neutral $20 → $2.40
Dec-29-14Reiterated ROTH Capital Buy $28 → $20
Nov-18-14Initiated H.C. Wainwright Buy $7
Jun-10-24 07:00AM
Jun-05-24 07:00AM
May-29-24 07:00AM
May-27-24 07:00AM
May-23-24 07:00AM
07:00AM Loading…
May-13-24 07:00AM
May-10-24 09:00AM
May-09-24 07:00AM
May-06-24 07:00AM
Apr-29-24 09:00AM
Apr-25-24 07:00AM
Apr-15-24 07:00AM
Apr-03-24 07:00AM
Apr-01-24 07:00AM
07:00AM Loading…
Mar-28-24 07:00AM
Mar-11-24 07:00AM
Feb-28-24 07:00AM
Jan-30-24 07:00AM
Jan-29-24 07:00AM
Dec-20-23 07:00AM
Dec-18-23 07:00AM
Dec-04-23 07:00AM
Nov-30-23 07:00AM
Nov-22-23 07:23AM
Nov-21-23 01:53PM
Nov-01-23 07:00AM
Oct-30-23 09:55AM
10:00AM Loading…
Oct-27-23 10:00AM
Oct-26-23 07:00AM
Oct-09-23 07:00AM
Sep-27-23 07:00AM
Sep-07-23 07:00AM
Aug-31-23 07:00AM
Aug-24-23 07:10AM
Aug-18-23 07:00AM
Aug-08-23 07:00AM
Jul-17-23 07:00AM
Jul-11-23 07:00AM
Jul-07-23 07:00AM
Jun-29-23 07:00AM
Jun-14-23 12:17PM
Jun-13-23 07:00AM
Jun-02-23 07:00AM
Jun-01-23 07:00AM
May-30-23 07:00AM
May-15-23 07:00AM
May-10-23 12:00PM
May-09-23 07:00AM
May-02-23 07:00AM
Apr-24-23 07:00AM
Apr-10-23 07:00AM
Mar-30-23 07:15AM
Mar-16-23 07:00AM
Mar-13-23 07:00AM
Feb-14-23 07:00AM
Jan-24-23 07:00AM
Jan-11-23 09:04AM
Jan-10-23 07:00AM
Dec-30-22 04:30PM
Dec-29-22 10:18AM
Dec-28-22 10:21AM
Dec-27-22 08:00AM
Dec-08-22 07:00AM
Nov-25-22 07:00AM
Nov-10-22 02:13PM
Nov-04-22 10:54AM
Nov-02-22 07:15AM
Oct-31-22 09:15AM
Oct-25-22 07:00AM
Oct-13-22 07:00AM
Sep-23-22 08:00AM
Sep-12-22 07:00AM
Aug-25-22 07:00AM
Aug-23-22 07:00AM
Aug-22-22 07:00AM
Aug-17-22 07:25AM
Jul-11-22 07:00AM
Jun-29-22 07:46AM
Jun-24-22 07:00AM
Jun-09-22 07:00AM
May-26-22 07:00AM
May-16-22 07:00AM
May-02-22 07:00AM
Apr-05-22 07:00AM
Mar-28-22 07:00AM
Mar-24-22 08:30AM
Mar-14-22 07:00AM
Mar-11-22 07:00AM
Mar-08-22 08:35AM
Jan-31-22 07:00AM
Jan-13-22 08:44AM
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.